We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$10.6B
AUM Growth
+$848M
Cap. Flow
+$62.2M
Cap. Flow %
0.59%
Top 10 Hldgs %
71.15%
Holding
98
New
8
Increased
14
Reduced
33
Closed
5

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$491M
2
ALGN icon
Align Technology
ALGN
+$16.7M
3
HDB icon
HDFC Bank
HDB
+$15.4M
4
NVCR icon
NovoCure
NVCR
+$13M
5
AXNX
Axonics, Inc. Common Stock
AXNX
+$7.97M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$35M
3
HD icon
Home Depot
HD
+$30.3M
4
AMZN icon
Amazon
AMZN
+$23.6M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$21.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.07%
2 Technology 17.27%
3 Healthcare 16.19%
4 Financials 15.23%
5 Communication Services 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
26
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$29.3M 0.28%
271,544
-25,000
-8% -$2.73M
DXCM icon
27
DexCom
DXCM
$31.5B
$28.5M 0.27%
212,000
-64,000
-23% -$9.2M
CNC icon
28
Centene
CNC
$30.7B
$27.6M 0.26%
334,756
-80,000
-19% -$5.86M
EXAS
29
DELISTED
Exact Sciences
EXAS
$25.9M 0.24%
332,341
+68,889
+26% +$6.08M
VRTX icon
30
Vertex Pharmaceuticals
VRTX
$121B
$23.8M 0.23%
108,557
ILMN icon
31
Illumina
ILMN
$31B
$22.1M 0.21%
59,601
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
$21.3M 0.2%
380,400
+130,400
+52% +$7.97M
TFX icon
33
Teleflex
TFX
$6.05B
$19.1M 0.18%
58,000
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$11.6B
$18.9M 0.18%
213,851
NVCR icon
35
NovoCure
NVCR
$1.73B
$18.2M 0.17%
241,784
+130,000
+116% +$13M
PRVA icon
36
Privia Health
PRVA
$2.98B
$17.3M 0.16%
670,000
+150,000
+29% +$3.74M
INFY icon
37
Infosys
INFY
$48.7B
$17M 0.16%
670,464
+57,370
+9% +$1.33M
PODD icon
38
Insulet
PODD
$11.5B
$16.7M 0.16%
62,908
-10,000
-14% -$2.9M
LHCG
39
DELISTED
LHC Group LLC
LHCG
$15.2M 0.14%
110,657
CHRS icon
40
Coherus Oncology
CHRS
$217M
$14.8M 0.14%
928,464
QDEL icon
41
QuidelOrtho
QDEL
$1.14B
$13.5M 0.13%
100,000
-40,000
-29% -$5.57M
OSH
42
DELISTED
Oak Street Health, Inc.
OSH
$13.4M 0.13%
404,933
+30,000
+8% +$1.14M
KRYS icon
43
Krystal Biotech
KRYS
$10.1B
$13M 0.12%
185,809
VCRA
44
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$12.3M 0.12%
190,058
ONEM
45
DELISTED
1Life Healthcare
ONEM
$11.7M 0.11%
665,000
+60,000
+10% +$1.16M
HRTX icon
46
Heron Therapeutics
HRTX
$93.9M
$11M 0.1%
1,202,069
SRPT icon
47
Sarepta Therapeutics
SRPT
$1.57B
$10.8M 0.1%
120,329
SCI icon
48
Service Corp International
SCI
$11.7B
$9.7M 0.09%
136,650
+7,996
+6% +$531K
KPTI icon
49
Karyopharm Therapeutics
KPTI
$43.5M
$9.64M 0.09%
100,000
+20,000
+25% +$1.99M
IRTC icon
50
iRhythm Holdings
IRTC
$3.85B
$9.41M 0.09%
80,000

Similar funds

C WorldWide Group's Q4 2021 Portfolio in Review

As of Q4 2021, C WorldWide Group held 98 positions worth $10.6B, up 8.7% from $9.74B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

C WorldWide Group's Q4 2021 filing shows 8 new, 14 increased, 33 reduced and 5 closed positions. Its largest new stake was Adobe: 785,781 shares worth $446M. The largest sale was Visa, an estimated $240M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • C WorldWide Group's largest Q4 2021 buy was Adobe: 785,781 shares worth $446M.
  • C WorldWide Group added most to Align Technology in Q4 2021, an estimated $16.7M increase.
  • C WorldWide Group's biggest Q4 2021 reduction was Visa, cutting an estimated $240M.
  • C WorldWide Group fully exited Fidelity National Information Services in Q4 2021, selling an estimated $2.04M.
  • C WorldWide Group's ten largest holdings make up 71% of its $10.6B portfolio in Q4 2021.
  • C WorldWide Group opened 8 new positions and closed 5 in Q4 2021.
  • C WorldWide Group's portfolio value rose 8.7% quarter-over-quarter to $10.6B.

Based on C WorldWide Group's 13F filing for Q4 2021, filed 2 Feb 2022.